Studying COVID-19 Persistence After Recovery

Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence

Recruiting Observational Study
COVID-19 Corona Virus Infection SARS-CoV 2
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
7 and older
Sex
Any
Study type
Observational
Participants needed
800 (estimated)
Sponsor
Columbia University · Other
Who this trial is looking for

This trial is looking for people who have recovered from COVID-19 and those who have never had it. Participants will provide samples and complete surveys over two years to help understand how the virus behaves after recovery.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with COVID-19 through lab testing or compatible symptoms
  • I have never tested positive for COVID-19
  • I am at least 7 years old
  • I can provide semen or breast milk if I am 18 years old or older

You may not be able to join if

  • I am under 7 years old
  • I have other health conditions that could affect the study results

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The 2019-2020 COVID-19 pandemic is the largest outbreak in recent history. It is not known how long after someone gets sick with COVID-19 and recovers that they can still infect other people. It is also not known how quickly people make antibodies against the virus, which help clear infection from the body. The investigators will enroll 300 people who had COVID-19 based on lab testing or confirmed…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Laboratory confirmed SARS-CoV-2 using currently available laboratory testing techniques (e.g.,RT-PCR, Immunoglobulin M (IgM) /IgG) or clinical history compatible with a COVID-19 like illness(fever, cough, shortness of breath). * Negative participants with no known prior COVID-…
Contacts

Michael Yin, MD, MS

212-305-7185

mty4@cumc.columbia.edu

CONTACT

Lawrence Purpura, MD, MPH

212-305-2220

lp2745@cumc.columbia.edu

CONTACT